GlassScriptPhysician profile
Bradley C Gill
NPI 1518223106
$139,589.35
in general payments reported to CMS, 2019-2025
22 companies · $26K in 2025
The $26K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,031 · 2020: $657 · 2021: $792 · 2022: $23K · 2023: $25K · 2024: $56K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $67K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Travel and Lodging: $11K · Food and Beverage: $8,876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $67,185.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,084.50 |
| Travel and Lodging | $11,279.07 |
| Food and Beverage | $8,876.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $103,862.62 | 2019-2025 | General - Erectile Dysfunction, Greenlight Xps, Rezum Generator |
| Sumitomo Pharma America, INC. | $25,609.06 | 2023-2025 | Gemtesa |
| Urovant Sciences INC | $3,230.01 | 2021-2022 | |
| Medtronic, INC. | $3,147.56 | 2021-2025 | Altaviva, Interstim |
| Medtronic USA, INC. | $1,190.94 | 2019-2020 | |
| Procept Biorobotics Corporation | $363.75 | 2022-2024 | Aquabeam System |
| Coloplast Corp | $361.54 | 2020-2024 | |
| Antares Pharma, INC. | $268.50 | 2021-2025 | Xyosted |
| Axonics, INC. | $263.86 | 2024 | Axonics, Bulkamid |
| Neotract INC. | $230.21 | 2019 | |
| Astellas Pharma US INC | $166.94 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $147.64 | 2019-2022 | |
| Janssen Biotech, INC. | $147.33 | 2019 | |
| Allergan, INC. | $142.26 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $138.00 | 2023 | Bard Urinary Drainage Bag |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $132.53 | 2019-2023 | Da Vinci Surgical System |
| Otsuka America Pharmaceutical, INC. | $57.14 | 2023-2024 | Jynarque |
| Novo Nordisk INC | $35.35 | 2023-2024 | Ozempic, Rybelsus |
| Richard Wolf Medical Instruments Corp. | $31.26 | 2019-2020 | |
| Pfizer INC. | $23.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.69 | 2023 | |
| Olympus America INC. | $19.37 | 2023 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.